TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: Cerenis Therapeutics (Paris:CEREN) (FR0012616852 – CEREN – PEA PME eligible), an international biopharmaceutical company dedicated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results